Cargando…
Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits
INTRODUCTION: The purpose of this study was to examine and compare the conjunctival irritation (congestion, swelling, and discharge) of topical bimatoprost ophthalmic solution 0.01% and bimatoprost ophthalmic solution 0.03% in rabbits. METHODS: Six healthy New Zealand White rabbits were treated with...
Autores principales: | , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827189/ https://www.ncbi.nlm.nih.gov/pubmed/20186281 |
_version_ | 1782177923145400320 |
---|---|
author | Ogundele, Abayomi B Li, Guangming Ellis, Joel J |
author_facet | Ogundele, Abayomi B Li, Guangming Ellis, Joel J |
author_sort | Ogundele, Abayomi B |
collection | PubMed |
description | INTRODUCTION: The purpose of this study was to examine and compare the conjunctival irritation (congestion, swelling, and discharge) of topical bimatoprost ophthalmic solution 0.01% and bimatoprost ophthalmic solution 0.03% in rabbits. METHODS: Six healthy New Zealand White rabbits were treated with either bimatoprost 0.01% or bimatoprost 0.03% (3 animals/group). One dose (2 drops/dose) of study medication was administered to the right eye of each animal every 30 minutes for 4.5 hours. Approximately 1 hour after the last dose, conjunctival irritation was assessed using a slit-lamp biomicroscope to individually evaluate conjunctival congestion, swelling, and discharge. RESULTS: The mean conjunctival congestion, swelling and discharge scores for bimatoprost 0.03% were 1.67, 0.33 and 0.33, respectively, and for bimatoprost 0.01% were 2.00, 0.33 and 1.33, respectively. CONCLUSIONS: Despite the lower drug concentration of the 0.01% formulation, bimatoprost 0.01% does not reduce conjunctival irritation, including conjunctival congestion, swelling, and discharge, in rabbits compared to bimatoprost 0.03%. Further studies would be needed to determine whether the increase in the mean conjunctival congestion and discharge scores may be attributed to the increased BAK concentration in the bimatoprost 0.01% formulation. |
format | Text |
id | pubmed-2827189 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-28271892010-02-25 Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits Ogundele, Abayomi B Li, Guangming Ellis, Joel J Clin Ophthalmol Original Research INTRODUCTION: The purpose of this study was to examine and compare the conjunctival irritation (congestion, swelling, and discharge) of topical bimatoprost ophthalmic solution 0.01% and bimatoprost ophthalmic solution 0.03% in rabbits. METHODS: Six healthy New Zealand White rabbits were treated with either bimatoprost 0.01% or bimatoprost 0.03% (3 animals/group). One dose (2 drops/dose) of study medication was administered to the right eye of each animal every 30 minutes for 4.5 hours. Approximately 1 hour after the last dose, conjunctival irritation was assessed using a slit-lamp biomicroscope to individually evaluate conjunctival congestion, swelling, and discharge. RESULTS: The mean conjunctival congestion, swelling and discharge scores for bimatoprost 0.03% were 1.67, 0.33 and 0.33, respectively, and for bimatoprost 0.01% were 2.00, 0.33 and 1.33, respectively. CONCLUSIONS: Despite the lower drug concentration of the 0.01% formulation, bimatoprost 0.01% does not reduce conjunctival irritation, including conjunctival congestion, swelling, and discharge, in rabbits compared to bimatoprost 0.03%. Further studies would be needed to determine whether the increase in the mean conjunctival congestion and discharge scores may be attributed to the increased BAK concentration in the bimatoprost 0.01% formulation. Dove Medical Press 2010 2010-02-18 /pmc/articles/PMC2827189/ /pubmed/20186281 Text en © 2010 Ogundele et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Ogundele, Abayomi B Li, Guangming Ellis, Joel J Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits |
title | Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits |
title_full | Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits |
title_fullStr | Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits |
title_full_unstemmed | Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits |
title_short | Impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits |
title_sort | impact of topical bimatoprost 0.01% and bimatoprost 0.03% on conjunctival irritation in rabbits |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2827189/ https://www.ncbi.nlm.nih.gov/pubmed/20186281 |
work_keys_str_mv | AT ogundeleabayomib impactoftopicalbimatoprost001andbimatoprost003onconjunctivalirritationinrabbits AT liguangming impactoftopicalbimatoprost001andbimatoprost003onconjunctivalirritationinrabbits AT ellisjoelj impactoftopicalbimatoprost001andbimatoprost003onconjunctivalirritationinrabbits |